JOHNSON & JOHNSON (JNJ)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for JNJ
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| JNJ | Independent Director | 71 | ["Distinguished Professor of Biology and Oncological Sciences at University of Utah","Chief Executive Officer Emerita at Huntsman Cancer Institute","Expertise in scientific research and organizational management in the healthcare arena","Active participant in national and international scientific affairs","Strong focus on patient experience"] | ["Chair, Science & Technology","Member, Regulatory Compliance & Sustainability"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| EXEL | Independent Director | 71 | ["Distinguished Professor of Biology and Oncological Sciences at the University of Utah","Chief Executive Officer of the Huntsman Cancer Institute from 2006 to 2025","Board member of Huntsman Corporation since 2011","Board member of Johnson & Johnson since 2015","Member of various scientific and advisory boards","NACD Corporate Governance Fellow","NACD Directorship 100 Honoree","Elected member of the National Academy of Sciences","Elected member of the American Philosophical Society","Elected member of the American Academy of Arts and Sciences","B.A. in Biology and Psychology (magna cum laude) from Wells College","Ph.D. in Molecular, Cellular and Developmental Biology from the University of Colorado, Boulder","Post-doctoral fellowship in Anatomy and Cell Biology at the University of North Carolina at Chapel Hill"] | ["Governance Committee","Research & Development Committee","Risk Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Age: 71 Independent Director since 2015 Committees: Chair, Science & Technology Member, Regulatory Compliance & Sustainability Career highlights University of Utah (current) Distinguished Professor of Biology and Oncological Sciences Huntsman Cancer Institute Chief Executive Officer Emerita Other public board service Exelixis (since 2024) Huntsman Corporation (since 2011) Other affiliations Medical Advisory Board, Howard Hughes Medical Institute Board of Scientific Advisors, National Cancer Institute (2018-2022) Advisory Committee to the Director, National Institute of Health (2007-2010; 2024-2025) Director, American Association for Cancer Research (2013-2016) President, American Society for Cell Biology (2006-2007) Elected membership to National Academy of Sciences, American Philosophical Society, and American Academy of Arts and Sciences Skills & qualifications Expertise in scientific research and organizational management in the healthcare arena Active participant in national and international scientific affairs Strong focus on patient experience